Restenosis: Do we need to understand it to treat it?

Journal of the American College of Cardiology

Volumn 40, Issue 12, 2002, Pages 2090-2091

  Faxon, David ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ATHERECTOMY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; HUMAN; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; STENT; TREATMENT OUTCOME;

EID: 0037132636     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02596-2     Document Type: Editorial

References (17)

1. Grüentzig AR, King SB III, Schlumpf M, Siegenthaler W. Longterm follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. N Engl J Med 1987;316:1127-32.
2. Mehran R, Dangas G, Abizaid AS, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999;100:1872-8.
3. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: Have we been aiming at the wrong target? (review). J Am Coll Cardiol 1995;25:516-20.
4. Kimura T, Kaburagi S, Tamura T, et al. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Clinical Investigation and Report: Coronary Heart Disease/Interventional Procedures. Circulation 1997;96:475-83.
5. Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: Perspectives from multicenter clinical trials. J Am Coll Cardiol 2002;40:2082-9.
6. Teirstein PS, Massullo V, Jani S, et al. Three-year clinical and angiographic follow-up after intracoronary radiation. Results of a randomized clinical trial. Circulation 2000;101:360-5.
7. Leon MB, Teirstein PS, Moses JW, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-6.
8. Verin V, Popowski Y, de Bruyne B, et al. Endoluminal beta-radiation therapy for the prevention of coronary restenosis after balloon angioplasty. N Engl J Med 2001;344:243-9.
9. Waksman R, Ajani AE, White RL, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med 2002;346:1194-9.
10. Ajani AE, Waksman R. The WRIST series - What have we learnt? Herz 2002;27:23-9.
11. Kuntz RE. The beta-cath system trial. Presented at Late Breaking Trials, American College of Cardiology Scientific Sessions, March 18, 2002.
12. Sousa EJ, Costa MS, Abizaid AC, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up. Circulation 2001;104:2007-11.
13. Morice M-C, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80.
14. Grube E, Serruys PW. Safety and performance of a paclitaxel-eluting stent for the treatment of in-stent restenosis: Preliminary results of the TAXUS III Trial (abstr). J Am Coll Cardiol 2002;39:58A.
15. Chevalier B, de Scheerder I, Gershlick A, et al. Effect on restenosis with a paclitaxel eluting stent: Factors associated with inhibition in the Elutes Clinical Study (abstr). J Am Coll Cardiol 2002;39:59A.
16. Serruys PW, Abizaid A, Foley D, et al. Sirolimus-eluting stents abolish neointimal hyperplasia in patients with in-stent restenosis: Late angiographic and intravascular ultrasound results (abstr). J Am Coll Cardiol 2002;39:37A.
17. Chung I-M, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002;40:2072-81.